These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25433009)

  • 21. HIV-1 pretreatment drug resistance and genetic transmission network in the southwest border region of China.
    Li D; Chen H; Li H; Ma Y; Dong L; Dai J; Jin X; Yang M; Zeng Z; Sun P; Song Z; Chen M
    BMC Infect Dis; 2022 Sep; 22(1):741. PubMed ID: 36117159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China.
    Liu M; He XQ; Deng RN; Tang SQ; Harypursat V; Lu YQ; He K; Huo Q; Yang HH; Liu Q; Chen YK
    HIV Med; 2022 Mar; 23 Suppl 1(Suppl 1):95-105. PubMed ID: 35293098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV type 1 virological response and prevalence of HIV type 1 drug resistance among patients receiving antiretroviral therapy, Shandong, China.
    Zhang J; Kang D; Lin B; Sun X; Fu J; Bi Z; Nkengasong JN; Yang C
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1658-65. PubMed ID: 22563717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of HIV type 1 antiretroviral drug resistance mutations in Vietnam: a multicenter study.
    Dean J; Ta Thi TH; Dunford L; Carr MJ; Nguyen LT; Coughlan S; Connell J; Nguyen HT; Hall WW; Nguyen Thi LA
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):797-801. PubMed ID: 21366425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone.
    Yendewa GA; Sahr F; Lakoh S; Ruiz M; Patiño L; Tabernilla A; Deen GF; Sesay M; Salata RA; Poveda E
    J Antimicrob Chemother; 2019 Jul; 74(7):2024-2029. PubMed ID: 30989237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities.
    Ross L; Lim ML; Liao Q; Wine B; Rodriguez AE; Weinberg W; Shaefer M
    HIV Clin Trials; 2007; 8(1):1-8. PubMed ID: 17434843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam.
    Tanuma J; Quang VM; Hachiya A; Joya A; Watanabe K; Gatanaga H; Van Vinh Chau N; Chinh NT; Oka S
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):358-64. PubMed ID: 24815852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
    Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon.
    Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P
    J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Drug Resistance Detected by Next-Generation Sequencing among ART-Naïve Individuals: A Systematic Review and Meta-Analysis.
    Ouyang F; Yuan D; Zhai W; Liu S; Zhou Y; Yang H
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
    Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
    PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
    Hamers RL; Sigaloff KC; Wensing AM; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Stevens WS; Rinke de Wit TF; Schuurman R;
    Clin Infect Dis; 2012 Jun; 54(11):1660-9. PubMed ID: 22474222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of HIV-1 primary drug resistance on the efficacy of a first-line antiretroviral regimen in the blood of newly diagnosed individuals in Bamako, Mali.
    Keita A; Sereme Y; Pillet S; Coulibaly S; Diallo F; Pozzetto B; Thiero TA; Bourlet T
    J Antimicrob Chemother; 2019 Jan; 74(1):165-171. PubMed ID: 30285106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid HIV-1 drug resistance testing in a resource limited setting: the Pan Degenerate Amplification and Adaptation assay (PANDAA).
    Kouamou V; Ndhlovu CE; Katzenstein D; Manasa J
    Pan Afr Med J; 2021; 40():57. PubMed ID: 34795836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
    Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M
    AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.
    Liu L; Dong A; Liao L; Feng Y; Shao Y; Liang S; Ruan Y; Xing H
    Curr HIV Res; 2019; 17(6):441-451. PubMed ID: 31778107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
    Loubet P; Charpentier C; Visseaux B; Borbor A; Nuta C; Adu E; Chapplain JM; Baysah M; Tattevin P; Yazdanpanah Y; Descamps D
    J Antimicrob Chemother; 2015; 70(6):1881-4. PubMed ID: 25698771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 pretreatment drug resistance in vertically infected children is associated with poor virological response to protease inhibitor (PI)-based first-line antiretroviral therapy (ART): results from a cohort study in Argentina.
    Rozenszajn M; Arazi-Caillaud S; Taicz M; Bologna R; Mangano A; Aulicino PC
    J Antimicrob Chemother; 2022 Jun; 77(7):1969-1973. PubMed ID: 35512329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure.
    Vandenhende MA; Bellecave P; Recordon-Pinson P; Reigadas S; Bidet Y; Bruyand M; Bonnet F; Lazaro E; Neau D; Fleury H; Dabis F; Morlat P; Masquelier B
    PLoS One; 2014; 9(1):e86771. PubMed ID: 24475178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.